First Light Asset Management, LLC
Top Portfolio Positions
35 positions ·
$1,176,236,598 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| AXGN |
Axogen, Inc.
Healthcare
|
4,002,768 | $132,611,703 | 11.27% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
980,758 | $122,251,484 | 10.39% | |
| NEO |
Neogenomics Inc
Healthcare
|
9,729,978 | $72,196,436 | 6.14% | |
| NPCE |
NeuroPace Inc
Healthcare
|
5,415,389 | $71,212,364 | 6.05% | |
| SIBN |
SI-BONE, Inc.
Healthcare
|
5,353,190 | $67,610,789 | 5.75% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
1,560,991 | $62,002,562 | 5.27% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
576,684 | $48,539,492 | 4.13% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
3,190,645 | $44,349,965 | 3.77% | |
| TLSI |
TriSalus Life Sciences, Inc.
Healthcare
|
10,440,944 | $41,763,776 | 3.55% | |
| TWST |
Twist Bioscience Corp
Healthcare
|
878,848 | $41,762,856 | 3.55% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CNTA
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,002,562 | 1,560,991 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $56,996,289 | 2,278,940 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $88,168,538 | 3,635,816 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $56,415,420 | 4,293,411 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $70,089,903 | 4,874,124 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $97,236,832 | 5,805,184 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $94,982,710 | 5,940,132 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $43,168,456 | 4,780,560 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $33,923,108 | 3,002,045 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||